Collaborative fellowship targets critical gap in Bone Marrow Failure Syndromes and childhood cancer

Children's Cancer CoLab and Maddie Riewoldt's Vision have launched a new fellowship, investing up to $250,000 to support a clinician-researcher working at the intersection of Bone Marrow Failure Syndromes and paediatric oncology.
The Children's Cancer CoLab and Maddie Riewoldt's Vision Clinician-Researcher Fellowship addresses the critical talent shortage in this specialised field, where genetic mutations affecting bone marrow can cause both Bone Marrow Failure Syndromes and rare cancers in children.
The two non-profit organisations have partnered to co-invest in this fellowship to accelerate research aligned with their missions and improve outcomes for children and families affected by these devastating conditions.
In Australia, three children die every week from cancer, with one in five not surviving their diagnosis. Meanwhile, up to 160 people are diagnosed with a Bone Marrow Failure Syndrome every year. Distressingly, most of them are children and young adults and 50% will not survive.
The initiative emerges from a recently signed Memorandum of Understanding between the two organisations, reflecting their shared recognition that breakthroughs often happen when unexpected connections are made between related conditions.
Children’s Cancer CoLab CEO, Dr Udani Reets, said the partnership reflected a shared commitment to driving meaningful change for those impacted by these rare life-threatening illnesses.
“By combining our expertise and resources, we can accelerate research progress and offer renewed hope to young patients and families affected by Bone Marrow Failure Syndromes and cancer."
CEO of Maddie Riewoldt's Vision, Amy Coote, said this fellowship would address a critical research gap.
“Supporting emerging clinician-researchers at the crucial intersection of Bone Marrow Failure Syndromes and paediatric oncology means investing in future leaders who will deliver the breakthroughs needed to improve outcomes and create brighter futures for young patients and their families.”
The fellowship provides clinicians with foundational support, mentorship, and protected time to develop research capabilities and establish themselves as leaders. A special Scientific Advisory Committee from both organisations designed the program and will assess applications to ensure meaningful impact in this interdisciplinary field.
Applications are now open for this unique opportunity to support the next generation of clinician-researchers working to transform outcomes for children and families affected by Bone Marrow Failure Syndromes and childhood cancer.
For more information and to apply for this fellowship, go to the Children's Cancer CoLab and Maddie Riewoldt's Vision Clinician-Researcher Fellowship webpage. Applications close 17 October 2025.
Share our stories
All stories published by Children’s Cancer CoLab can be shared under a Creative Commons Attribution-NonCommercial 4.0 International license, which means you're welcome to share and adapt our content with proper attribution using the details below.
Sign up to our newsletter
Stay connected with Children’s Cancer CoLab.
More ways you can make an impact
Your support drives critical research and innovation that will change lives. By supporting Children's Cancer CoLab, you become part of a community working to ensure every young patient with cancer survives and thrives. Our approach unites top researchers across disciplines and institutions, breaking traditional barriers to accelerate discoveries from the lab to clinic, creating real impact for young cancer patients and their families.